These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36586013)

  • 21. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
    Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
    Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.
    Warrington K; Hillarby MC; Li C; Letarte M; Kumar S
    Anticancer Res; 2005; 25(3B):1851-64. PubMed ID: 16158917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
    Lv S; Tao L; Liao H; Huang Z; Lu Y
    Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
    Zhang XF; Weng DS; Pan K; Zhou ZQ; Pan QZ; Zhao JJ; Tang Y; Jiang SS; Chen CL; Li YQ; Zhang HX; Chang AE; Wicha MS; Zeng YX; Li Q; Xia JC
    Mol Carcinog; 2017 Nov; 56(11):2499-2511. PubMed ID: 28621442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
    Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
    Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno EM; Abbruzzese A; Rossi G
    Int J Oncol; 2005 May; 26(5):1193-201. PubMed ID: 15809709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma.
    Saroufim A; Messai Y; Hasmim M; Rioux N; Iacovelli R; Verhoest G; Bensalah K; Patard JJ; Albiges L; Azzarone B; Escudier B; Chouaib S
    Br J Cancer; 2014 Apr; 110(7):1778-84. PubMed ID: 24594997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.
    Nassiri F; Cusimano MD; Scheithauer BW; Rotondo F; Fazio A; Yousef GM; Syro LV; Kovacs K; Lloyd RV
    Anticancer Res; 2011 Jun; 31(6):2283-90. PubMed ID: 21737653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
    Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
    Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Klimovich VB
    Vopr Onkol; 2015; 61(6):898-907. PubMed ID: 26995976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
    Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
    Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological analysis of angiogenic factors in renal cell carcinoma.
    Yagasaki H; Kawata N; Takimoto Y; Nemoto N
    Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
    Li C; Guo B; Bernabeu C; Kumar S
    Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD105 prevents apoptosis in hypoxic endothelial cells.
    Li C; Issa R; Kumar P; Hampson IN; Lopez-Novoa JM; Bernabeu C; Kumar S
    J Cell Sci; 2003 Jul; 116(Pt 13):2677-85. PubMed ID: 12746487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
    Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD105 as a tool for assessing microvessel density in renal cell carcinoma.
    Cioca A; Muntean D; Bungardean C
    Indian J Pathol Microbiol; 2019; 62(2):239-243. PubMed ID: 30971547
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.